by RNA | Apr 20, 2022 | Client Success, Valuation Advisory
By Jeff Suchocki, CFA The Situation: Adoption of ASC 842 – Lease Accounting is mandatory for all private companies for fiscal years beginning after December 15, 2021. To comply with this mandatory adoption requirement, a privately held, clinical stage biotech company... Read More
by RNA | Jul 12, 2017 | Valuation Advisory
Value is ultimately what parties agree to. Sometimes this seems rational, other times irrational. The reality is that value often results from the ability or inability to create an effective bidding process and to persuade/anchor a strategic counterparty toward your... Read More
by RNA | Jul 11, 2017 | Valuation Advisory
In finance, theories about the efficiency of markets have been both extraordinarily elegant and disastrously wrong on many occasions. These so-called efficient markets concepts have brought about interesting tools like the Capital Asset Pricing Model and Black-Scholes... Read More
by RNA | Oct 20, 2016 | Client Success
THE PROBLEM: Novel technology platform could be used across a wide range of rare diseases, so executive team and board want an independent, evidence-based view of commercial opportunity to complement the scientific analysis. THE SOLUTION: Interviews with KOL... Read More
